Report #2895533

Received May 6, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 11 yrs
State: CA
Recovered: Unknown
Vaccinated: Feb 4, 2026
Onset: Feb 4, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	Y013818	OT / RA

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

No additional AE; improperly stored AE for GARDASIL-9; This spontaneous report was received from a office menager and refers to 11-year-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) and Diphtheria vaccine toxoid; Pertussis vaccine acellular 3-component; Tetanus vaccine toxoid (BOOSTRIX). On 04-Feb-2026, the patient was vaccinated with improperly stored the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9) (valid lot #Y013818, expiration date: 12-Feb-2027), administered by Intramuscular route in Right Arm as prophylaxis (product storage issue). No additional adverse event (AE) was reported,

Other medications

MenQuadfi; Boostrix